SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-136119
Filing Date
2018-04-27
Accepted
2018-04-26 21:47:03
Documents
3
Period of Report
2018-04-25
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d544097d8ka.htm 8-K/A 15958
2 EX-5.1 d544097dex51.htm EX-5.1 7404
3 GRAPHIC g544097g05g76.jpg GRAPHIC 6661
  Complete submission text file 0001193125-18-136119.txt   33798
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-30171 | Film No.: 18780763
SIC: 2836 Biological Products, (No Diagnostic Substances)